Modern Approaches to Combining Sirolimus With Calcineurin Inhibitors

Transplantation Proceedings

Volumn 40, Issue 10 SUPPL., 2008, Pages

  Stevens, R B ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; DRUG SUBSTITUTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADRENAL CORTEX HORMONES; ANIMALS; ANTILYMPHOCYTE SERUM; CALCINEURIN; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PREDNISONE; PROBABILITY; RABBITS; SIROLIMUS; SURVIVAL ANALYSIS; SURVIVORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 57649085799     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.012     Document Type: Article

References (12)

1. Kaneku H.K., and Terasaki P.I. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry. Clin Transpl (2006) 1
2. Halloran P.F. Immunosuppressive drugs for kidney transplantation. N Engl J Med 351 (2004) 2715
3. Nankivell B.J., and Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 81 (2006) 643
4. Stevens R.B., Mercer D.F., and Grant W.J. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation 85 (2008) 1391
5. Kyllonen L.E., Eklund B.H., and Pesonen E.J. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation 84 (2007) 75
6. Starzl T.E., Murase N., and Abu-Elmagd K. Tolerogenic immunosuppression for organ transplantation. Lancet 361 (2003) 1502
7. Flechner S.M., Kobashigawa J., and Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 22 (2008) 1
8. Kahan B.D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 356 (2000) 194
9. Kaplan B., and Kirk A.D. Tacrolimus and sirolimus: when bad things happen to good drugs. Am J Transplant 6 (2006) 1501
10. Gallon L., Perico N., and Dimitrov B.D. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 6 (2006) 1617
11. Stevens R.B., Wrenshall L.E., and Mercer D.F. Long term follow-up after early steroid withdrawal and calcineurin-inhibitor minimization in moderate to high immunologic risk renal transplant recipients including ABO incompatible and donor-specific antibody (2008), American Transplant Congress, Toronto, Ontario, Canada
12. Halloran P.F., Aprile M.A., and Farewell V. Early function as the principal correlate of graft survival: a multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 46 (1988) 223